Continuing Education

Objective: Cancer survivors with symptomatic severe aortic stenosis and a history of chest radiation therapy represent a complex and challenging

Introduction: Cardiac Implantable Electronic Device (CIED) infections are a major source of morbidity, mortality and increased healthcare cost. There are

Background: In patients with ST-segment-elevation myocardial infarction (MI), timely treatment with primary percutaneous coronary intervention (PPCI) with door-to-balloon (D2B) time

Background: The number of older adults admitted to cardiac intensive care units (CICU) have been increasing over the past decade,

Background: The association between psychiatric illness, coronary artery disease (CAD) and mortality is poorly understood. It has been theorized that

Introduction: Significant atrioventricular blocks and bradyarrhythmias are known complications of open-heart surgery. These are frequently transient, however, some patients go

Introduction: Despite significant increase in intravenous tissue plasminogen activator (IV tPA) treatment rates in the US, only 9.0% of patients

Background: It is well known that there is a significant gender gap in both the referral and outcomes of patients

Background: Concerns exist that mortality benefit might vary across different drugs (canagliflozin, empagliflozin, dapagliflozin) belonging to sodium-glucose cotransporter-2 (SGLT2) inhibitors.

Background: Cardiovascular disease (CVD) and cancer are the leading causes of mortality among adult women in the United States (US),